Related Experiment Video

Updated: Sep 13, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Giant cell arteritis

J M Calvo-Romero1

  • 1Internal Medicine, Hospital de Zafra, Antigua Ctra Nacional 432, Spain. jmcromero@eresmas.com

Postgraduate Medical Journal
|September 19, 2003
PubMed

Insights

Giant cell arteritis (GCA), a large vessel vasculitis, affects individuals over 50. With proper treatment, mortality rates for GCA patients are comparable to the general population.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA), also known as temporal arteritis or Horton's arteritis, is a systemic vasculitis affecting large and medium-sized arteries.
  • It predominantly impacts individuals over 50 years of age, with a particular predilection for the extracranial branches of the carotid arteries.

Purpose of the Study:

  • To summarize the key aspects of Giant Cell Arteritis, including its pathophysiology, clinical manifestations, and management.
  • To highlight the significant complications associated with GCA and the established treatment protocols.

Main Methods:

  • Review of existing literature on Giant Cell Arteritis.
  • Analysis of clinical characteristics, diagnostic criteria, and treatment outcomes.

Main Results:

  • GCA is characterized by inflammation of large and medium vessels, particularly cranial arteries.
  • Feared complications include permanent visual loss, ischemic strokes, and aortic aneurysms.
  • High-dose corticosteroids are the primary treatment modality.

Conclusions:

  • Prompt and appropriate treatment of GCA with high-dose steroids is crucial for managing the condition.
  • With effective treatment, the mortality rate in GCA patients appears to be similar to that of age-matched controls.
  • Early diagnosis and management are essential to prevent severe complications and ensure favorable outcomes.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...